Michel Detheux Ph.D.
Net Worth

Last updated:

What is Michel Detheux Ph.D. net worth?

The estimated net worth of Dr. Michel Detheux Ph.D. is at least $11,805,098 as of 18 Apr 2022. He owns shares worth $266,044 as insider, has earned $8,204,054 from insider trading and has received compensation worth at least $3,335,000 in iTeos Therapeutics, Inc..

What is the salary of Michel Detheux Ph.D.?

Dr. Michel Detheux Ph.D. salary is $833,750 per year as Pres, Chief Executive Officer & Director in iTeos Therapeutics, Inc..

How old is Michel Detheux Ph.D.?

Dr. Michel Detheux Ph.D. is 59 years old, born in 1966.

What stocks does Michel Detheux Ph.D. currently own?

As insider, Dr. Michel Detheux Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
iTeos Therapeutics, Inc. (ITOS) Pres, Chief Executive Officer & Director 26,263 $10.13 $266,044

What does iTeos Therapeutics, Inc. do?

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

ITOS logo
ITOS
iTeos Therapeutics, Inc.
$10.13

Michel Detheux Ph.D. insider trading

iTeos Therapeutics, Inc.

Dr. Michel Detheux Ph.D. has made 31 insider trades between 2021-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 30,000 units of ITOS stock on 22 Dec 2021. As of 18 Apr 2022 he still owns at least 26,263 units of ITOS stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 11,500 $4.23 $48,645
Option
Stock Option (Right to Buy) 11,500 $4.23 $48,645
Sale
Common Stock 33 $32.64 $1,077
Sale
Common Stock 11,467 $31.87 $365,453
Sale
Common Stock 1,159 $35.22 $40,820
Sale
Common Stock 1,548 $36.51 $56,517
Sale
Common Stock 5,822 $33.44 $194,688
Sale
Common Stock 9,908 $34.11 $337,962
Sale
Common Stock 544 $35.32 $19,214
Sale
Common Stock 13,956 $34.3 $478,691
Sale
Common Stock 10,088 $35.45 $357,620
Sale
Common Stock 4,412 $36.21 $159,759
Option
Stock Option (Right to Buy) 30,000 $4.3 $129,000
Sale
Common Stock 16,163 $44.81 $724,183
Option
Common Stock 1,663 $4.3 $7,151
Sale
Common Stock 19,226 $44.61 $857,576
Option
Common Stock 19,226 $4.3 $82,672
Sale
Common Stock 9,111 $43.94 $400,337
Option
Common Stock 9,111 $4.3 $39,177
Option
Stock Option (right to buy) 16,263 $12.45 $202,474
Sale
Common Stock 14,500 $36.08 $523,160
Option
Common Stock 16,263 $12.45 $202,474
Sale
Common Stock 6,085 $28.89 $175,777
Sale
Common Stock 14,391 $28.42 $408,920
Sale
Common Stock 81 $28 $2,268
Sale
Common Stock 196 $28 $5,488
Sale
Common Stock 201 $28 $5,628
Sale
Common Stock 1,089 $28.02 $30,512
Sale
Common Stock 5,322 $28.16 $149,862
Sale
Common Stock 11,568 $29.2 $337,832
Sale
Common Stock 8,684 $28.3 $245,722
Sale
Common Stock 4,093 $28.12 $115,095
Sale
Common Stock 2,322 $28.01 $65,039
Sale
Common Stock 8,248 $28.17 $232,346
Sale
Common Stock 861 $28 $24,109
Sale
Common Stock 225 $28.26 $6,359
Sale
Common Stock 7,499 $28.06 $210,422
Sale
Common Stock 29,000 $28.82 $835,809
Sale
Common Stock 29,000 $28.82 $835,809

iTeos Therapeutics key executives

iTeos Therapeutics, Inc. executives and other stock owners filed with the SEC: